Gemcitabine 5'-diphosphate
Gemcitabine 5'-diphosphate (dFdCDP) is a core active metabolic intermediate of Gemcitabine (HY-17026) and a potent ribonucleotide reductase (RNR) inhibitor. Gemcitabine 5'-diphosphate depletes deoxyribonucleotide pools, consumes deoxycytidine triphosphate and increases the phosphorylation level of gemcitabine. Gemcitabine 5'-diphosphate prolongs the intracellular retention duration of gemcitabine metabolites, enhances the nucleic acid incorporation of gemcitabine, and exerts anti-tumor/cytotoxic effects.
For research use only. We do not sell to patients.
- CAS No.: 116371-66-5
- Formula: C9H13F2N3O10P2
- Molecular Weight:423.16
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Gemcitabine 5'-diphosphate potently inhibits ribonucleotide reductase, depleting deoxyribonucleotide pools and enhancing gemcitabine phosphorylation via reduced dCTP-mediated feedback inhibition of dCK[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 116371-66-5
-
Molecular Weight 423.16
-
Formula C9H13F2N3O10P2
-
SMILES
NC(C=CN1[C@H]2C(F)(F)[C@H](O)[C@@H](COP(OP(O)(O)=O)(O)=O)O2)=NC1=O
-
Synonyms
dFdCDP
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Mini E, et al. Cellular pharmacology of gemcitabine. Annals of oncology : official journal of the European Society for Medical Oncology. 2006 May;17 Suppl 5:v7-12. [Content Brief]
[2]. Derissen EJB, et al. Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides. British journal of clinical pharmacology. 2018 Jun;84(6):1279-1289. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Gemcitabine 5'-diphosphate
- 116371-66-5
- dFdCDP
- Drug Metabolite
- DNA/RNA Synthesis
- metastatic pancreatic cancer
- peripheral blood mononuclear cells
- ovarian cancer
- mesothelioma
- breast cancer
- ribonucleotide reductase
- deoxyribonucleotide pools
- bladder cancer
- non-small cell lung cancer
- deoxycytidine triphosphate
- Inhibitor
- inhibitor
- inhibit